MedTrace Logo

Minimally Invasive Surgery for Spontaneous Deep Intracerebral Hemorrhage

NCT07710313 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2026-07-17

No results posted yet for this study

Summary

This observational cohort study evaluates the real-world effectiveness and safety of minimally invasive surgery (MIS) versus standard medical management in adults with spontaneous deep intracerebral hemorrhage. Patients presenting to Tam Anh General Hospital and People's Hospital 115 within 72 hours of hemorrhage onset will be enrolled and followed for 180 days. Clinical, radiological, and treatment-related variables will be collected, with primary outcome measures including survival and functional outcomes during follow-up period.

Conditions

  • Intracerebral Hemorrhage
  • Spontaneous Intracerebral Hemorrhage
  • Basal Ganglia Hemorrhage

Interventions

PROCEDURE

Minimally Invasive Surgery (MIS)

Patients with spontaneous deep intracerebral hemorrhage who undergo minimally invasive surgery as part of routine clinical care. Decisions regarding surgical treatment and timing are made by the treating physicians according to standard practice. Clinical outcomes and safety outcomes will be evaluated through 180 days of follow-up.

OTHER

Standard medical treatment (SMT)

Participants receive standard medical management according to current clinical practice guidelines for spontaneous intracerebral hemorrhage. Treatment decisions are made by the treating physicians. Clinical and safety outcomes will be evaluated through 180 days of follow-up.

Sponsors & Collaborators

  • Tam Anh TP. Ho Chi Minh General Hospital

    collaborator OTHER

  • People's Hospital 115

    collaborator UNKNOWN

  • Tam Anh Research Institute

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-01
Primary Completion
2028-12-31
Completion
2028-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07710313 on ClinicalTrials.gov